Analyzing the options chain and the chart patterns of CLRB Cellectar Biosciences prior to the earnings report this week, I would consider purchasing the 5usd strike price in the money Puts with an expiration date of 2024-4-19, for a premium of approximately $1.15. If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Welcome to RiskMastery's Breakout Stocks - Stocks with breakout potential . In this edition, we'll be looking at NASDAQ:CLRB ... I believe this code is at a point of potential volatility. If price can hold above $3.50 ... Bullish potential may be unlocked. My key upside targets include: - $5.70 (Conservative) - $6.80 (Medium) - $9.95 (Aggressive) ...
Contextual immersion trading strategy idea. Cellectar Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next...
If clears resistance could hit analysts target.
They have an upside price target of 5.40. There a few resistance points but I will probably set my long term target at the top green marker on the chart. A downfall from time to time is the volume on this stock. Cellectar Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for...
This would could be 60-120% gianer if you get in correctly. I am waiting maybe tomorrow or day just depends. I want to know we have a bottom here. LONG.
Historical support at 2 dollars. I’m anticipating a bounce.
Positive news today "CLR 131 Achieves 50% Overall Response Rate in Cohort 6 of Ongoing Phase 1 Study in Relapsed or Refractory Multiple Myeloma". This stock Shs Float is 5.15M, and Market Cap 14.76M.
CLRB has a buy rating on Zacks Rank, but it has poor financial. Based on my experience (or lack of) studying the graph, I expect the stock will drop in the future. At the moment the stock is $4.08.
Waiting for Phase 2 data to restart the hype for this low floater.
Very interesting to see this stock bottom, breakout, and GAP fill in 1 trading session.